Treatment-resistant Schizophrenia: Evidence-based Strategies.

Mens Sana Monogr · 2012 · PMC3353603 · PMID 22654380

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In parallel, the SSNRI bupropion showed a trend for improving cognitive performance in schizophrenia but needs to be further evaluated.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.